JP Morgan Chase
SLXP

JP Morgan Chase’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

JP Morgan Chase’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-440,180
Closed -$76.1M – 4367
2015
Q1 		$76.1M Sell
440,180
-577,447
-57% -$84.8M 0.02% 725
2014
Q4 		$117M Buy
1,017,627
+202,950
+25% +$24.6M 0.03% 580
2014
Q3 		$127M Buy
814,677
+590,282
+263% +$85.6M 0.03% 535
2014
Q2 		$27.7M Sell
224,395
-281,113
-56% -$31.1M 0.01% 1144
2014
Q1 		$52.4M Buy
505,508
+351,196
+228% +$36M 0.01% 787
2013
Q4 		$13.9M Buy
154,312
+29,818
+24% +$2.38M ﹤0.01% 1571
2013
Q3 		$8.32M Sell
124,494
-250,032
-67% -$17.2M ﹤0.01% 1867
2013
Q2 		$24.8M Buy
+374,526
New +$21.4M 0.01% 1120

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

JP Morgan Chase's SLXP Position: Q2 2015 in Review

JP Morgan Chase sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 440,180 shares — an estimated $76.1M sold.

JP Morgan Chase first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $127M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • JP Morgan Chase reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • JP Morgan Chase sold 440,180 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $76.1M.
  • JP Morgan Chase first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • JP Morgan Chase's SALIX PHARMACEUTICALS LTD DEL position peaked at $127M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.